Evogene (EVGN) Reports Q3 Loss of $0.57/Share
Get Alerts EVGN Hot Sheet
Join SI Premium – FREE
Evogene (NASDAQ: EVGN) reported Q3 EPS of ($0.57), versus ($0.51) reported last year. Revenue for the quarter came in at $2.65 million, versus $5.36 million reported last year.
For earnings history and earnings-related data on Evogene (EVGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- XPeng (XPEV) posts better-than-expected earnings, margin for Q4; stock climbs
- Core & Main, Inc (CNM) Tops Q1 EPS by 1c ; Offers Guidance
- Oppenheimer Reiterates Outperform Rating on Fiserv (FI)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!